NECTIN4 and neoplasm: We set up immunocompetent murine models of human nectin4-positive tumors by transgenically expressing hN4 in LLC1 cells, an immunologically desert type of tumor syngeneic with C57BL/6, and in the immunogenic CT26 and Renca tumors, syngeneic with BALB/c mice.